NCT04227496 is a NA clinical trial of Auditory disturbances in Healthy, sponsored by University College of Northern Denmark.

Who is sponsoring NCT04227496?

NCT04227496 is sponsored by University College of Northern Denmark.

What drugs are being tested in NCT04227496?

Interventions in NCT04227496: Auditory disturbances.

What condition does NCT04227496 study?

NCT04227496 studies Healthy, Pain.

Is NCT04227496 still recruiting?

NCT04227496 is currently status unknown. Last updated 13 January 2020.

Last reviewed 2020-01-13 · How we verify

NCT04227496

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Auditory Disturbances on Human Movement

Status unknown NA Last updated 13 January 2020

What this trial tests

NA trial testing Auditory disturbances in Healthy in 40 participants. Status unknown.

Timeline

13 January 2020

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	University College of Northern Denmark
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	basic science
Enrollment	40
Start date	13 January 2020
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across Denmark

Drugs / interventions tested

Auditory disturbances

Conditions studied

Healthy — all drugs for Healthy →
Pain — all drugs for Pain →

Sponsor

University College of Northern Denmark

Who can join

Adults 18 to 50, any sex, with Healthy or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study sets out to investigate the potential effect of auditory disturbances on human movement

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University College of Northern Denmark trials

Trials by the same sponsor.

NCT06487741 — Efficacy of a Home-based Stretching Program on Fibromyalgia Symptoms: a Randomised Controlled Trial · NA · recruiting
NCT06176053 — Feasibility and Acceptability of Home-based Stretching Exercises in Fibromyalgia · NA · completed
NCT05989490 — The Effect of Stretching Intensity on Pain Sensitivity · NA · completed
NCT04919681 — Efficacy of Stretching on Pain Sensitivity · NA · completed
NCT05015946 — Handball-based Exercise and Type 2 Diabetes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04227496 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University College of Northern Denmark
Last refreshed: 13 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04227496.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing